New Corporate Presentation

RNS Number : 7451B

Open Orphan PLC

03 February 2020

 

03 February 2020

RNS REACH

Open Orphan plc

("Open Orphan", the "Company" or the "Group")

New Corporate Presentation

Open Orphan plc (ORPH), the rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, is pleased to announce the latest copy of its investor presentation is now available to view on https://www.openorphan.com/investors/reasons-invest.

Open Orphan was also covered this weekend in the Sunday Times due to our unique reputation as being the world leader in this space having provided services for over 30 years to the vaccine production companies around the world.

https://www.thetimes.co.uk/article/irish-firm-open-orphan-lined-up-for-role-in-coronavirus-fight-kgrnkp3f5

For further information please contact

Open Orphan plc Cathal Friel, Executive Chairman               Trevor Phillips, Chief Executive Officer	[phone] [phone]
Arden Partners plc (Nominated Adviser and Joint Broker) John Llewellyn-Lloyd / Benjamin Cryer	[phone]
Davy (Euronext Growth Adviser and Joint Broker) Anthony Farrell	[phone]
Camarco (Financial PR)
Tom Huddart / Daniel Sherwen	[phone]

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

END

 

 

NRAUOURRRBUURAR